Next-gen HA Fillers
Aesthetic Medicine
R&D/RegistrationIn Development
Key Facts
Indication
Aesthetic Medicine
Phase
R&D/Registration
Status
In Development
Company
About Imeik Technology Development
Imeik Technology Development's mission is to leverage biotechnology to create beauty and health, aiming to enhance life quality and dignity. The company has achieved market leadership in China's medical aesthetics sector through its proprietary hyaluronic acid technology platform and a vertically integrated business model encompassing R&D, manufacturing, and professional education. Its strategy focuses on deepening its core aesthetic product portfolio while expanding into adjacent regenerative medicine and skincare markets, supported by significant R&D investment and a direct-to-practitioner engagement model. A successful 2020 IPO on the Shenzhen Stock Exchange has provided capital to accelerate this growth trajectory.
View full company profile